More articles from Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction

You have access
Evaluation of Alteration in Hepatic and Intestinal BCRP Function In Vivo from ABCG2 c.421C>A Polymorphism Based on PBPK Analysis of Rosuvastatin
Azusa Futatsugi, Kota Toshimoto, Takashi Yoshikado, Yuichi Sugiyama and Yukio Kato

Drug Metabolism and Disposition May 2018, 46 (5) 749-757; DOI: https://doi.org/10.1124/dmd.117.078816
You have access
Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity
Rachel J. Eclov, Mee J. Kim, Robin Smith, Nadav Ahituv and Deanna L. Kroetz

Drug Metabolism and Disposition May 2018, 46 (5) 636-642; DOI: https://doi.org/10.1124/dmd.117.079541
You have access
Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study
Kristin E. Follman and Marilyn E. Morris

Drug Metabolism and Disposition May 2018, 46 (5) 758-769; DOI: https://doi.org/10.1124/dmd.117.079558
You have access
Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction
Qingcheng Mao, Yurong Lai and Joanne Wang

Drug Metabolism and Disposition May 2018, 46 (5) 561-566; DOI: https://doi.org/10.1124/dmd.118.081356
You have access
Hepatic Transport of 25-Hydroxyvitamin D₃ Conjugates: A Mechanism of 25-Hydroxyvitamin D₃ Delivery to the Intestinal Tract
Chunying Gao, Michael Z. Liao, Lyrialle W. Han, Kenneth E. Thummel and Qingcheng Mao

Drug Metabolism and Disposition May 2018, 46 (5) 581-591; DOI: https://doi.org/10.1124/dmd.117.078881
You have access
Physiologically Based Pharmacokinetic Modeling of Bosentan Identifies the Saturable Hepatic Uptake As a Major Contributor to Its Nonlinear Pharmacokinetics
Masanobu Sato, Kota Toshimoto, Atsuko Tomaru, Takashi Yoshikado, Yuta Tanaka, Akihiro Hisaka, Wooin Lee and Yuichi Sugiyama

Drug Metabolism and Disposition May 2018, 46 (5) 740-748; DOI: https://doi.org/10.1124/dmd.117.078972
You have access
Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter–Enzyme Interplay
Norikazu Matsunaga, Yukina Fukuchi, Haruo Imawaka and Ikumi Tamai

Drug Metabolism and Disposition May 2018, 46 (5) 680-691; DOI: https://doi.org/10.1124/dmd.117.079236
You have access
Liver Zonation Index of Drug Transporter and Metabolizing Enzyme Protein Expressions in Mouse Liver Acinus
Masanori Tachikawa, Yuna Sumiyoshiya, Daisuke Saigusa, Kazunari Sasaki, Michitoshi Watanabe, Yasuo Uchida and Tetsuya Terasaki

Drug Metabolism and Disposition May 2018, 46 (5) 610-618; DOI: https://doi.org/10.1124/dmd.117.079244
Open Access
Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity
Tom T. G. Nieskens, Janny G. P. Peters, Dina Dabaghie, Daphne Korte, Katja Jansen, Alexander H. Van Asbeck, Neslihan N. Tavraz, Thomas Friedrich, Frans G. M. Russel, Rosalinde Masereeuw and Martijn J. Wilmer

Drug Metabolism and Disposition May 2018, 46 (5) 592-599; DOI: https://doi.org/10.1124/dmd.117.079384
Open Access
Identification of Structural and Molecular Features Involved in the Transport of 3′-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3
MD Fazlur Rahman, Radhika Raj and Rajgopal Govindarajan

Drug Metabolism and Disposition May 2018, 46 (5) 600-609; DOI: https://doi.org/10.1124/dmd.117.079400

Main menu

User menu

Search

More articles from Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction

Pages

Navigate

More Information

ASPET's Other Journals